drug evaluation

Explore academic connections and research related to this keyword

272
Views
7
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
A cost-effectiveness model for coronary thrombolysis/reperfusion therapy
Laffel GL;Fineberg HV;Braunwald E;;
1987 Journal of the American College of Cardiology 397 views
2
Prophylactic oxacillin in dog bite wounds
Elenbaas RM;McNabney WK;Robinson WA;;
1982 Annals of emergency medicine 378 views
3
Loperamide in the treatment of acute gastroenteritis in early childhood. Report of a two centre, double-blind, controlled clinical trial
Owens JR;Broadhead R;Hendrickse RG;Jaswal OP;Gangal RN;;
1981 annals of tropical paediatrics 333 views
4
In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses
Hasui M;Matsuda M;Okutani K;Shigeta S;;
1995 International journal of biological macromolecules 624 views
5
Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence
Colombo G;Agabio R;Carai MA;Lobina C;Pani M;Reali R;Addolorato G;Gessa GL;;
2000 Alcoholism, clinical and experimental research 278 views
6
Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine
Hayden FG;Sperber SJ;Belshe RB;Clover RD;Hay AJ;Pyke S;;
1991 Antimicrobial agents and chemotherapy 257 views
7
Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice
Ilyushina NA;Hoffmann E;Salomon R;Webster RG;Govorkova EA;;
2007 antiviral therapy 254 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine models Recurrence risk factors time factors decision trees theoretical* cost-benefit analysis pmid:2959718 doi:10.1016/s0735-1097(87)80432-1 g l laffel h v fineberg